- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Not active orphans
- Recombinant fusion protein consisting of the extracellular p
Pharmaceuticals - Community Register
Community list of not active orphan medicinal products |
WITHDRAWN |
Product information |
Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain
EU orphan designation number: | EU/3/10/812 |
Active ingredient: | Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain |
Indication: | Treatment of Duchenne muscular dystrophy |
Sponsor: | Shire Pharmaceuticals Ireland Limited
5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland |
Public summary of scientific opinion
European Commission procedures |